Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update

Atukuri Dorababu1

  • 1SRMPP Government First Grade College, Huvinahadagali, Karnataka, India.

Archiv Der Pharmazie
|June 13, 2022
PubMed

Insights

Fused heterocyclic compounds, specifically pyrazolopyrimidines, show significant potential as drug candidates. This review highlights their diverse anticancer, antimicrobial, and anti-inflammatory activities, aiding future drug design.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Cancer, microbial infections, and inflammation are major global health concerns with limited effective treatments.
  • Heterocyclic compounds, particularly fused systems, are crucial scaffolds in modern drug design.
  • Pyrazolopyrimidines have demonstrated significant biological activities, making them promising therapeutic agents.

Purpose of the Study:

  • To systematically review the diverse pharmacological activities of pyrazolopyrimidine derivatives.
  • To focus on anticancer, antimicrobial, anti-inflammatory, and enzyme inhibitory properties.
  • To provide insights into structure-activity relationships for future drug design.

Main Methods:

  • Comprehensive literature search of pyrazolopyrimidine derivatives reported in the last five years.
  • Categorization of reviewed studies based on pharmacological activity (anticancer, antimicrobial, anti-inflammatory, enzyme inhibitors).
  • Analysis and brief discussion of structure-activity relationships.

Main Results:

  • Pyrazolopyrimidine derivatives exhibit a broad spectrum of potent pharmacological activities.
  • Significant anticancer, antimicrobial, and anti-inflammatory effects were documented.
  • Enzyme inhibitory activities were also reported for various derivatives.

Conclusions:

  • Pyrazolopyrimidine derivatives represent a valuable class of compounds for developing novel therapeutic agents.
  • Further research into structure-activity relationships can optimize the design of potent drugs.
  • These compounds hold promise for addressing unmet medical needs in cancer, infectious diseases, and inflammatory conditions.

Related Concept Videos

Basicity of Heterocyclic Aromatic Amines01:25

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...